Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Rabies Vaccine (Vero Cell) Immunogenicity and Safety Trial
CTR20130859Phase 3Completed
- Sponsor
- Jilin Maifeng
- Start
- Jan 2018
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of Purified Vero cell rabies vaccine in rabies, sponsored by Jilin Maifeng. Started Jan 2018; status: completed.
02
Drugs
Purified Vero cell rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on CTR20130859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130859.